Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Organization National Institutes of HealthPosted 28 Oct 2024Deadline 7 Jan 2028
HHS-NIH1193.85393.866synopsis
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Opportunity Number: PAR-25-024 Document Type: synopsis CFDA Numbers: 93.853, 93.866

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →